Evidence map›Paper›PMID 33776589›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2020

Mumps outbreaks across Canada, 2016 to 2018.

Myriam Saboui, Susan G Squires

Abstract read
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Myriam SabouiCentre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.
Susan G SquiresCentre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn increase in mumps incidence was observed in late 2016 (365 cases in 2016 compared to 59 cases in 2015). This unusual level of mumps activity prompted the Public Health Network Council and the National Advisory Committee on Immunization to request situation awareness updates from the Centre for Immunization and Respiratory Infectious Diseases (CIRID) at the Public Health Agency of Canada in 2017 and 2018.

methodsA mumps outbreak survey was developed and administered by epidemiologists within CIRID and sent electronically to provincial and territorial public health officials in charge of mumps surveillance. The survey collected information on mumps outbreaks pertaining to demographics, risk factors, laboratory data and public health interventions. The first survey collected data on outbreaks occurring between January 1, 2016 and February 28, 2017, while the second survey contained outbreak data from January 1, 2017 to July 31, 2018. Duplicate outbreaks entries were removed.

resultsThe response rate for the first and second surveys was 61% and 69%, respectively. Twenty-four mumps outbreaks across nine provinces were reported between January 1, 2016 and July 31, 2018, for a cumulative total of 881 mumps cases. Adolescents and adults 15 to 39 years of age accounted for the majority of cases (80.6%). Specifically, adults 20 to 24 years of age represented the largest proportion of cases (24.6%). Community and social gatherings were the most common exposure setting (62.5%). Slightly more than one third of cases were known to have received at least two doses of mumps-containing vaccine (35.6%).

conclusionResults from the surveys indicate that the increase in mumps activity was widespread throughout Canada, affecting multiple jurisdictions. Young adults accounted for the largest proportion of cases. These surveys provided evidence to support recommendations on the use of additional mumps vaccination in outbreak settings.

Indexed as

Canadamumpsoutbreaksurvey

Identifiers

PMID33776589
PMCPMC7986990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.